All Videos Educational Technical Support Products Customer
Illumina at the Festival of Genomics & Biodata 2023

352 views | 5 days ago

The annual London event featured sessions with genomics leaders and showcased the NovaSeq X series. #genomics #FoG2023 Subscribe to the Illumina video channel

Illumina Connected Analytics Cohorts: Multi-Omic Cancer Workflow

407 views | 2 weeks ago

Building cases and controls out of complex genomic and phenotypic data to uncover biomarkers of interest is difficult at scale. The fundamental starting point is cohort selection. This demonstration...

Conhecer opções para expandir o rastreio genético pré-natal com o teste pré-natal não invasivo

45 views | 1 month ago

Esta série de vídeos fornece algumas informações básicas sobre os testes genéticos pré-natais para ajudá-la a tomar decisões com base naquilo que mais importa para si. Assista a todos os vídeos desta...

Illumina Polygenic Risk Score Solution

783 views | 2 months ago

The Illumina Polygenic Risk Score solution is a comprehensive, easy-to-implement, and versatile genomic analysis tool set for translational researchers. Featuring the Infinium Global Diversity Array...

Illumina® | Introducing the NovaSeq™ 6000Dx. A new era for the clinical lab.

877 views | 3 months ago

The NovaSeq 6000Dx offers immense diagnostic power in an FDA-registered, CE-marked next-generation sequencing platform. From an integrated, unified interface, users can run the NovaSeq 6000Dx instrument...

Illumina GDT Virtual Panels

462 views | 3 months ago

Subscribe to the Illumina video channel A global genomics leader, Illumina provides comprehensive next-generation sequencing solutions...

Illumina Oncology - Homologous Recombination Deficiency (HRD) Testing in Ovarian Cancer

422 views | 3 months ago

Isabelle Ray-Coquard, MD, PhD, explains how comprehensive genomic profiling (CGP) simultaneously provides HRD and _BRCA_ status in ovarian cancer patients. She presents the case of a patient who benefited...

Illumina Oncology - Testing for 𝘕𝘛𝘙𝘒 fusions

340 views | 3 months ago

Vivek Subbiah, MD, explains how patients with rare and common tumors can benefit from next generation sequencing-based testing for _NTRK_ gene fusions. He presents the case of a patient who benefited...